Análisis costo-efectividad de Apixaban versus Enoxaparina en pacientes sometidos a reemplazo total de cadera o rodilla en Colombia

Apixaban is a cost-saving thromboprophylaxis strategy in patients undergoing THR or TKR in Colombia, as it prevents more VTE events, bleeding, and all-cause death, generating more LYG and QALYs, and its discounted costs are lower.